Revision history of "Suppressive myeloid cells as new functional biomarkers of aggressiveness in multiple sclerosis: relationship with tissue damage and neuro-repair." (Q3207972)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 March 2024

22 December 2023

12 June 2023

10 June 2023

18 August 2022

  • curprev 11:4111:41, 18 August 2022DG Regio talk contribs 76,314 bytes +52,358 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

5 December 2021

13 October 2021

  • curprev 01:0301:03, 13 October 2021DG Regio talk contribs 12,816 bytes +205 Changed label, description and/or aliases in en: translated_label
  • curprev 01:0301:03, 13 October 2021DG Regio talk contribs 12,611 bytes +2,382 Created claim: summary (P836): Multiple sclerosis (MS) is the most common neurological disease, being especially dramatic because it debuts mainly in young adults and is not cured. Existing treatments to date address the immune component of the disease and are only effective in the outbreak variant, MS-recurrent-remitting (MS-RR). Therefore, the search for any molecular/cellular factor capable of differentiating at the pathophysiological level the intrinsic reasons for these...

11 October 2021

10 October 2021

9 October 2021